How many insider trades does FilingIQ track for RVMD?

FilingIQ tracks 675 Form 4 insider transactions for RVMD (Revolution Medicines, Inc.), covering filings from Feb 18, 2020 onwards. 56 of those were filed in the last 90 days.

Are RVMD insiders net buyers or net sellers?

Across the full Form 4 history for RVMD, 40 transactions (6%) were open-market purchases and 356 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RVMD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RVMD in?

Revolution Medicines, Inc. (RVMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $18.93B.

RVMD insider trading

Healthcare

Revolution Medicines, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

675

Last 90 days

Buys / sells

6% / 53%

Market cap

$18.93B

About Revolution Medicines, Inc.

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Company website: www.revmed.com

RVMD insider activity at a glance

FilingIQ has scored 675 insider transactions for RVMD since Feb 18, 2020. The most recent filing in our index is dated Apr 27, 2026.

Across the full history, 40 open-market purchases and 356 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RVMD insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RVMD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding RVMD

Avoro Capital Advisors LLC

$172.84M · 1.7% of AUM

Casdin Capital, LLC

$171.03M · 13.1% of AUM

AH Capital Management, L.L.C.

$163.39M · 10.1% of AUM

Logos Global Management LP

$46.57M · 3.7% of AUM

Artal Group S.A.

$42.50M · 1.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for RVMD?: FilingIQ tracks 675 Form 4 insider transactions for RVMD (Revolution Medicines, Inc.), covering filings from Feb 18, 2020 onwards. 56 of those were filed in the last 90 days.
Are RVMD insiders net buyers or net sellers?: Across the full Form 4 history for RVMD, 40 transactions (6%) were open-market purchases and 356 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RVMD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RVMD in?: Revolution Medicines, Inc. (RVMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $18.93B.

Methodology & sources

Every RVMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.